O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer’s disease and related tauopathies: analysis of the patent literature-Reference-Cited by-同舟云学术

O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer’s disease and related tauopathies: analysis of the patent literature

Published:2021-07-08 Issue:12 Volume:31 Page:1117-1154
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Bartolomé-Nebreda Jose M.¹,Trabanco Andrés A.¹,Velter Adriana Ingrid²,Buijnsters Peter²

Affiliation:

1. A Division of Janssen-Cilag SA, Discovery Chemistry Department, Discovery, Product Development & Supply, Janssen Research and Development, Toledo, Spain

2. A Division of Janssen Pharmaceutica NV, Discovery Chemistry Department, Discovery, Product Development & Supply, Janssen Research and Development, Beerse, Belgium

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1947242

Reference146 articles.

1. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc.

2. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc.

3. Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc

4. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins

5. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O-GlcNAc Modification of α-Synuclein Can Alter Monomer Dynamics to Control Aggregation Kinetics;ACS Chemical Neuroscience;2024-07-31

2. Recent Advances in the Treatment and Management of Alzheimer’sDisease: A Precision Medicine Perspective;Current Topics in Medicinal Chemistry;2024-07

3. Diaminocyclopentane – l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase;Bioorganic Chemistry;2024-07

4. O-GlcNAcylation and immune cell signaling: A review of known and a preview of unknown;Journal of Biological Chemistry;2024-06

5. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review;Neurology and Therapy;2024-05-14